CervoMed CRVO
NASDAQ CRVO
$2.62 +0.06 (+2.34%)
At close: Aug 21, 2026 · 4:00 PM EDT

CervoMed (CRVO) Non-Current Deferred Tax Liability (2013 - 2021)

CervoMed (CRVO) posted Non-Current Deferred Tax Liability of $443893.0 for Q2 2021, little changed sequentially from $443893.0 in Q1 2021, and down 64.48% YoY from $1.2 million in Q2 2020.

CervoMed (CRVO) Non-Current Deferred Tax Liability (2013 - 2021) Analysis & Trends

CervoMed has reported Non-Current Deferred Tax Liability for 9 years, with the latest figure at $443893.0 in Q2 2021.

  • Quarterly Non-Current Deferred Tax Liability fell 64.48% year-over-year to $443893.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $443893.0 (down 64.48% YoY) and the FY2020 annual result came in at $443893.0, down 79.05% from the prior year.
  • Non-Current Deferred Tax Liability steadied at $443893.0 in Q2 2021 per CRVO's latest filing, from $443893.0 in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $3.3 million in Q1 2017 and troughed at $443893.0 in Q3 2020.
  • A 5-year average of $1.7 million and a median of $1.7 million in 2018 frame the typical range for Non-Current Deferred Tax Liability.
  • The sharpest annual moves came in 2019 and 2020: Non-Current Deferred Tax Liability grew 18.63% in 2019, then plunged 79.05% in 2020.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $2.2 million in 2017, then retreated by 19.67% to $1.8 million in 2018, then rose by 18.63% to $2.1 million in 2019, then slumped by 79.05% to $443893.0 in 2020, then changed by 0.0% to $443893.0 in 2021.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $443893.0, $443893.0, and $443893.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 CervoMed 26.64 Mn 26.64 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 443,893.00
Jun 30, 2021 443,893.00
Mar 31, 2021 443,893.00
Mar 31, 2021 443,893.00
Dec 31, 2020 443,893.00
Dec 31, 2020 443,893.00
Sep 30, 2020 443,893.00
Sep 30, 2020 443,893.00
Jun 30, 2020 1.25 Mn
Jun 30, 2020 1.25 Mn
Mar 31, 2020 1.76 Mn
Mar 31, 2020 1.76 Mn
Dec 31, 2019 2.12 Mn
Dec 31, 2019 2.12 Mn
Sep 30, 2019 1.30 Mn
Sep 30, 2019 1.30 Mn
Jun 30, 2019 1.53 Mn
Jun 30, 2019 1.53 Mn
Mar 31, 2019 1.64 Mn
Mar 31, 2019 1.64 Mn